Broadening the horizons for yellow fever: new uses for an old vaccine

Broadening the horizons for yellow fever

The vaccine against yellow fever is one of the safest and most effective ever developed. With an outstanding record in humans, has this live attenuated vaccine been overlooked as a promising vector for the development of vaccines against pathogens outside its own genus? Recent studies, including a report by Tao et al. on page 201 of this issue, have sparked renewed interest.

Yellow Fever Vaccination: An Issue for Non-endemic Tropical Countries

Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017

Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the immunization of U.S. travelers by mid-2017. CDC, the Food and Drug Administration (FDA), and Sanofi Pasteur are collaborating to ensure a continuous yellow fever vaccine supply in the United State...

iMedPub Journals ARCHIVES OF CLINICAL MICROBIOLOGY

Title: Multi-system organ failure following administration of yellow fever vaccine: a case report Background: Yellow fever vaccine-associated viscerotropic disease (YEL-AVD), is an extremely rare and life-threatening condition that occurs shortly after administration of the vaccine. It is characterized by multi-system organ failure including hemorrhagic fever, shock, renal failure, and hepatic ...

Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk.

OBJECTIVE To describe a case of infant meningoencephalitis that was probably caused by yellow fever vaccine virus transmitted via breastmilk. DESCRIPTION A 38-day old patient was admitted to hospital on May 23, 2009, with fever. On May 25, 2009, convulsive crises began. Cerebrospinal fluid (CSF) test results were suggestive of meningoencephalitis. The mother had been given a dose of yellow fe...